Articles by Disease (Hematological Malignancies)

Targeting Tumor Suppressor p53 for Cancer Therapy: Strategies, Challenges and Opportunities

Journal: Current Drug Targets
Volume: 15
Page: 80-89
Author(s): Bo Hong, A. Pieter J. van den Heuvel, Varun V. Prabhu, Shengliang Zhang and Wafik S. El-Deiry

Therapeutic Targeting of Cancers with Loss of PTEN Function

Journal: Current Drug Targets
Volume: 15
Page: 65-79
Author(s): Lloye M. Dillon and Todd W. Miller

Understanding XPO1 Target Networks Using Systems Biology and Mathematical Modeling

Journal: Current Pharmaceutical Design
Volume: 20
Page: 56-65
Author(s): Irfana Muqbil, Michael Kauffman, Sharon Shacham, Ramzi M. Mohammad and Asfar S. Azmi

The mTOR Signaling Pathway is an Emerging Therapeutic Target in Multiple Myeloma

Journal: Current Pharmaceutical Design
Volume: 20
Page: 125-135
Author(s): Jie Li, Jingyu Zhu, Biyin Cao and Xinliang Mao

Cyclophilin A as a Target of Cisplatin Chemosensitizers

Journal: Current Cancer Drug Targets
Volume: 14
Page: 46-58
Author(s): Gerhard Hamilton

New Approaches to Target Cancer Stem Cells: Current Scenario

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 14
Page: 20-34
Author(s): Mayank Bashyal Insan and Vikas Jaitak

Current Metabolomic Methodologies & their Application to Thermal Stress

Journal: Current Metabolomics
Volume: 1
Page: 335-352
Author(s): Sonia Gandhi, Subash Khushu and Rajendra P. Tripathi

Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy

Journal: Current Gene Therapy
Volume: 13
Page: 421-433
Author(s): William S.M. Wold and Karoly Toth

Biosafety Considerations Using Gamma-Retroviral Vectors in Gene Therapy

Journal: Current Gene Therapy
Volume: 13
Page: 469-477
Author(s): Annette Deichmann and Manfred Schmidt

Biosafety Challenges for Use of Lentiviral Vectors in Gene Therapy

Journal: Current Gene Therapy
Volume: 13
Page: 453-468
Author(s): Michael Rothe, Ute Modlich and Axel Schambach